Bio-Techne Corporation
TECH
$62.29
-$1.54-2.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.22B | 1.22B | 1.21B | 1.20B | 1.17B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.22B | 1.22B | 1.21B | 1.20B | 1.17B |
| Cost of Revenue | 403.53M | 408.52M | 403.75M | 400.67M | 395.05M |
| Gross Profit | 813.20M | 811.12M | 805.02M | 795.35M | 776.53M |
| SG&A Expenses | 459.37M | 448.79M | 491.16M | 449.45M | 436.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 962.77M | 956.80M | 983.12M | 942.93M | 922.17M |
| Operating Income | 253.97M | 262.83M | 225.65M | 253.09M | 249.42M |
| Income Before Tax | 106.28M | 98.46M | 162.98M | 185.79M | 176.30M |
| Income Tax Expenses | 28.30M | 25.06M | 31.32M | 27.66M | 25.59M |
| Earnings from Continuing Operations | 77.99 | 73.40 | 131.67 | 158.14 | 150.71 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 77.99M | 73.40M | 131.67M | 158.14M | 150.71M |
| EBIT | 253.97M | 262.83M | 225.65M | 253.09M | 249.42M |
| EBITDA | 360.07M | 372.73M | 336.50M | 363.68M | 360.72M |
| EPS Basic | 0.50 | 0.46 | 0.83 | 1.00 | 0.96 |
| Normalized Basic EPS | 1.01 | 1.04 | 0.86 | 0.95 | 0.93 |
| EPS Diluted | 0.48 | 0.45 | 0.83 | 1.00 | 0.95 |
| Normalized Diluted EPS | 1.00 | 1.03 | 0.85 | 0.93 | 0.92 |
| Average Basic Shares Outstanding | 626.18M | 629.25M | 632.20M | 632.14M | 631.24M |
| Average Diluted Shares Outstanding | 631.69M | 636.44M | 641.34M | 642.89M | 642.32M |
| Dividend Per Share | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
| Payout Ratio | 64.30% | 68.65% | 38.45% | 32.02% | 33.48% |